Clavicle fractures comprise 2% of all fractures and 35--45% of all shoulder girdle injuries in adults ([@CIT0019], [@CIT0022]). The incidence in western countries is around 50--64 per 10^5^ ([@CIT0019], [@CIT0020]). They are more common in men (68%) ([@CIT0022]).

Clavicle fractures are classified according to the anatomical site and degree of displacement ([@CIT0018], [@CIT0001], [@CIT0023]). Most clavicle fractures are situated in the middle part (81%), whereas lateral (17%) and medial fractures (2%) are much less common ([@CIT0022]).

By tradition, midshaft clavicle fractures have been treated nonoperatively with the arm immobilized in a sling for few weeks. The goal is to restore function of the upper extremity and to prevent any constant disability from the injury. Recently, there has been increasing interest in the operative treatment ([@CIT0003], [@CIT0026]).

In this systematic review, based on randomized controlled trials and controlled clinical trials, we assessed the effectiveness and adverse effects of operative and nonoperative treatment of acute clavicle fractures in adults.

Materials and methods {#ss2}
=====================

Methods for the inclusion and exclusion criteria, data extraction, and data synthesis were specified in advance and documented in a protocol.

Literature search {#ss3}
-----------------

An information specialist made an electronic database search of the literature without language restrictions using CDSR, DARE, CCTR, CINAHL, Ovid MEDLINE In-Process & Other Non-indexed Citations, Ovid MEDLINE, Journals\@Ovid, Current Controlled Trials Register, and EMBASE from 1966 until the end of March 2011. We used the following terms to search all trial registers and databases: fractures, fracture fixation, fracture healing, clavicle, and collar bone ([Appendix](#S1){ref-type="supplementary-material"}, see supplementary data). The latest search was run on March 31, 2011. Detailed search strategy is available from the authors. In addition, we contacted the study authors by e-mail to obtain more detailed information of studies.

Inclusion and exclusion criteria {#ss4}
--------------------------------

Eligible studies were randomized controlled trials and controlled clinical trials comparing operative with nonoperative treatment, operative treatment with another operative treatment, and nonoperative treatment with another nonoperative treatment for acute clavicle fractures. Studies had to involve at least 30 adult patients (≥ 18 years of age). The minimum follow-up time was 6 months. Our primary outcome measures were functional assessments: Constant shoulder score (CS), Disabilities of the Arm, Shoulder and Hand Score (DASH), and visual analog scale for pain (VAS). Secondary outcome measures were fracture union, range of motion (ROM), return to previous activity, and complications. We excluded studies dealing with non-acute fractures (treatment after 3 weeks) and 3 studies written in Chinese.

Study selection and assessment of methodological quality were done by 3 independent investigators (KV, MP, and VR). Discrepancy between investigators was solved by negotiation or, when necessary, by a fourth investigator (AM). We started with all the abstracts identified and excluded those that did not discuss the subject. From full text articles, we excluded retrospective trials and other studies that did not fulfill the eligibility criteria.

Data extraction and quality assessment {#ss5}
--------------------------------------

Data extraction from each study included was done by KV with a predetermined data extraction form. MP checked the extracted data. The data extraction form consisted of 3 sheets: (1) characteristics of the studies (author, study design, fracture location, fracture classification, fracture displacement, intervention, follow-up time, number of patients, and percentage of dropouts), (2) criteria for risk of bias, and (3) effectiveness of the study (primary and secondary outcome measures, complications, union, and nonunion). On assessing complications, we used recommendations of the Cochrane Handbook of Systematic Reviews of Interventions ([@CIT0017]). As suggested, we documented all reported complications in order to have wide coverage of the adverse effects. Assessment of risk of bias in trials was performed according to [@CIT0005]. We assessed the trials to have a low risk of bias if at least 6 out of 12 criteria were met. If the trials met less than 6 criteria, we rated the risk of bias as high.

Data synthesis {#ss6}
--------------

Due to the clinical heterogeneity in patient populations, treatments, outcomes, and fracture morphology, we could not pool the effect sizes in a meta-analysis. Instead, we summarized findings by strength of evidence. We used the difference in means as a summary measure. The overall quality was assessed by 3 authors (KV, MP, and AM). The evidence for each outcome was evaluated by using the GRADE approach, as recommended by the Cochrane Back Review Group ([@CIT0005]). The quality of the evidence on a specific outcome is based on 5 domains: (1) limitations of the study design, (2) inconsistency, (3) indirectness, (4) imprecision of results (insufficient or imprecise data), and (5) publication bias across all studies measuring that particular outcome. The quality starts at high when at least 2 high-quality RCTs provide results for the outcome, and is reduced by 1 level for each of the domains not met. The following criteria were used for assessment of the quality of evidence:

High-quality evidence = there are consistent findings in at least 75% of RCTs with no limitations of the study design, consistency, directness, or precision and no known or suspected publication bias. Moderate-quality evidence = 1 of the domains is not met. Low-quality evidence = 2 of the domains are not met. Very low-quality evidence = 3 of the domains are not met. No evidence = no RCTs were identified that addressed this outcome.

We considered a minimal clinically important difference in pain on the VAS scale to be more than 20 units ([@CIT0028]), and in disability more than 10 units of the DASH score ([@CIT0006], [@CIT0024]).

Results {#ss7}
=======

After elimination of duplicates, we found 1,072 abstracts from the electronic database searches reporting clavicle fractures. Most of the excluded studies did not address clavicle fractures or did not fulfill the inclusion criteria. For the thorough examination, we accepted 230 publications. From these studies, we judged 27 to be potentially appropriate. For the systematic review, 14 studies qualified, 6 of which were randomized controlled trials and 8 of which were controlled clinical trials ([Figure](#F1){ref-type="fig"}). We found 2 studies originating from the same patient population, and we have therefore only reported results from the more recent study ([@CIT0026], [@CIT0027]). Studies originated from several countries: Austria ([@CIT0026], [@CIT0027]), Canada ([@CIT0003]), China ([@CIT0025]), Germany ([@CIT0009], [@CIT0002]), India ([@CIT0011]), the Netherlands ([@CIT0007]), Taiwan ([@CIT0013], [@CIT0014], [@CIT0021], [@CIT0008]), the United Kingdom ([@CIT0004]), and the United States ([@CIT0010]). Only 1 study discussed lateral clavicle fractures ([@CIT0008]). We excluded 3 studies, since they were written in Chinese.

![Flow chart illustrating number of trials evaluated at each stage in the systematic review of clavicle fractures. **^a^** Studies are assessed to originate from the same patient population. Results are reported from the recent (2011) study, thus the final number of studies was 13.](ORT-0300-9734-083-065_g001){#F1}

[Table 1](#T1){ref-type="table"} lists study designs, patients, follow-up times, fracture types, interventions, and control treatments in the studies. The 13 studies involved 1,190 patients. There were 6 randomized controlled trials (631 patients) ([@CIT0007], [@CIT0003], [@CIT0025], [@CIT0010], [@CIT0004], [@CIT0027]) and 7 controlled clinical trials (559 patients) ([@CIT0009], [@CIT0013], [@CIT0014], [@CIT0021], [@CIT0008], [@CIT0002], [@CIT0011]). Sample sizes differed considerably (32--157 patients) between the studies. Follow-up times in the studies were long enough to evaluate the effect of the treatment after clavicle fracture (6--30 months).

###### 

Characteristics of the included studies (n=13) in systematic review of clavicle fractures

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  A                                                                 B     C   D            E                                                                  F                                                                 G                                                                 H           I         J
  ----------------------------------------------------------------- ----- --- ------------ ------------------------------------------------------------------ ----------------------------------------------------------------- ----------------------------------------------------------------- ----------- --------- ------
  [@CIT0007]\                                                       RCT   M   NM           \< / \>1 clavicle width                                            Rucksack bandage (78)                                             Mitella (79)                                                      10 months   157/152   3.2
  Netherlands                                                                                                                                                                                                                                                                                                           

  [@CIT0003]\                                                       RCT   M   NM           Completely displaced, no cortical contact between main fragments   Plate (67)                                                        Sling (65)                                                        1 year      132/111   15.9
  Canada                                                                                                                                                                                                                                                                                                                

  [@CIT0025]\                                                       RCT   M   NM           Compeletely displaced                                              3D reconstruction plate (67)                                      Superior reconstruction plate (66)                                1 year      133/117   12.0
  China                                                                                                                                                                                                                                                                                                                 

  [@CIT0010]\                                                       RCT   M   NM           Displaced or angulated                                             Hagie pin (29)                                                    Sling (28)                                                        1 year      57/50     12.3
  United States                                                                                                                                                                                                                                                                                                         

  [@CIT0026], [@CIT0027] Austria **[^b^](#T1-N2){ref-type="fn"}**   RCT   M   OTA          Displaced, no cortical contact between main fragments              ESIN (60)                                                         Sling (60)                                                        2 years     120/112   6.7

  [@CIT0004]\                                                       RCT   M   NM           Displaced and shortened with complete overlap of bone ends         Rockwood pin (17)                                                 Plate (15)                                                        1 year      32/32     0
  UK                                                                                                                                                                                                                                                                                                                    

  [@CIT0009]\                                                       CCT   M   Allman OTA   Allman I\                                                          ESIN (26)                                                         Rucksack bandage (27)                                             6 months    53/53     0
  Germany                                                                                  OTA A or B                                                                                                                                                                                                                   

  [@CIT0013]\                                                       CCT   M   NM           Not mentioned                                                      Knowles pin (32) **[^a^](#T1-N1){ref-type="fn"}**                 Dynamic compression plate (30) **[^a^](#T1-N1){ref-type="fn"}**   30 months   69/62     10.1
  Taiwan                                                                                                                                                                                                                                                                                                                

  [@CIT0014]\                                                       CCT   M   NM           Not mentioned                                                      Knowles pin (56) **[^a^](#T1-N1){ref-type="fn"}**                 Plate (32) **[^a^](#T1-N1){ref-type="fn"}**                       1 year      103/88    14.6
  Taiwan                                                                                                                                                                                                                                                                                                                

  [@CIT0021]\                                                       CCT   M   NM           Not mentioned                                                      Locking compression plate (29) **[^a^](#T1-N1){ref-type="fn"}**   Nonlocking plate (35) **[^a^](#T1-N1){ref-type="fn"}**            1 year      76/64     15.8
  Taiwan                                                                                                                                                                                                                                                                                                                

  [@CIT0008]\                                                       CCT   L   Neer         Neer II                                                            Hook plate (35)                                                   Tension band wire (30)                                            6 months    65/65     0
  Taiwan                                                                                                                                                                                                                                                                                                                

  [@CIT0002]\                                                       CCT   M   AO           AO 15-B: types A1, A2, B1, B2, C1, C2                              Plate (53)\                                                       Rucksack bandage (47)                                             8 months    120/96    20
  Germany                                                                                                                                                     ESIN (20)                                                                                                                                                 

  [@CIT0011], India                                                 CCT   M   OTA\         OTA 15-B\                                                          Plate (45)                                                        Sling (28)                                                        18 months   73/68     6.8
                                                                              Robinson     Robinson 2B1 and 2B2                                                                                                                                                                                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A Author, year, country

 COTS = Canadian Orthopaedic Trauma Society

B Study design

 RCT randomized controlled trial

 CCT controlled clinical trial

C Location of the fracture

 M middle

 L lateral

D Classification of the fracture

 NM not mentioned

E Displacement of the fracture

 OTA Orthopaedic Trauma Association

F Intervention (no. of patients)

 ESIN elastic stable intramedullary nail

G Control (no. of patients)

H Follow-up time

I No. of patients at initiation / at follow-up

J Percentage of drop-out

**^a^** Studies report no. of patients only at follow-up.

**^b^** Studies are assessed to originate from the same patient population. Results are reported from the recent (2011) study.

[Table 2](#T2){ref-type="table"} summarizes the methodological quality of the trials according to [@CIT0005]. Of 13 studies, 2 were considered to have a high risk of bias ([@CIT0002], [@CIT0027]).

###### 

Criteria for risk of bias assessment for the trials included (n=13) in the systematic review ([@CIT0005]). If ≥ 6 criteria were met, the trial is assessed to have low risk of bias

  Author, year, country                                              1\.   2\.       3\.       4\.       5\.   6\.       7\.       8\.   9\.   10\.   11\.   12\.      Total
  ------------------------------------------------------------------ ----- --------- --------- --------- ----- --------- --------- ----- ----- ------ ------ --------- -------
  Randomized controlled trials                                                                                                                                         
   [@CIT0007] Netherlands                                            Yes   Unclear   NA        NA        NA    No        Yes       Yes   Yes   Yes    Yes    Unclear   6
   [@CIT0003] Canada                                                 Yes   Yes       NA        NA        NA    No        Yes       Yes   Yes   Yes    Yes    Yes       8
   [@CIT0025] China                                                  Yes   Yes       Unclear   Unclear   Yes   No        Unclear   Yes   Yes   Yes    Yes    Yes       8
   [@CIT0010] United States                                          Yes   Yes       NA        NA        NA    No        Unclear   Yes   Yes   Yes    Yes    Yes       7
   [@CIT0026], [@CIT0027] Austria **[^a^](#T2-N1){ref-type="fn"}**   No    Unclear   NA        NA        NA    No        No        Yes   Yes   Yes    Yes    Yes       5
   [@CIT0004] United Kingdom                                         Yes   Yes       NA        NA        NA    Unclear   Yes       Yes   Yes   Yes    Yes    Unclear   7
  Controlled clinical trials                                                                                                                                           
   [@CIT0009] Germany                                                No    No        NA        NA        NA    Yes       Unclear   Yes   Yes   Yes    Yes    Yes       6
   [@CIT0013] Taiwan                                                 No    No        NA        NA        NA    Yes       Yes       Yes   Yes   Yes    Yes    Unclear   6
   [@CIT0014] Taiwan                                                 No    No        NA        NA        NA    Yes       Yes       Yes   Yes   Yes    Yes    Yes       7
   [@CIT0021] Taiwan                                                 No    No        No        NA        NA    Yes       Unclear   Yes   Yes   Yes    Yes    Yes       6
   [@CIT0004] Taiwan                                                 No    No        NA        NA        NA    Yes       Yes       Yes   Yes   Yes    Yes    Yes       7
   [@CIT0002] Germany                                                No    No        NA        NA        NA    No        Unclear   Yes   No    Yes    Yes    No        3
   [@CIT0011] India                                                  No    No        No        NA        NA    Yes       Yes       Yes   Yes   Yes    Yes    Yes       7

1\. Was the method of randomisation adequate?

2\. Was the treatment allocation concealed?

3\. Was the patient blinded to the intervention?

4\. Was the care provider blinded to the intervention?

5\. Was the outcome assessor blinded to the intervention?

6\. Was the drop-out rate described and acceptable?

7\. Were all randomized (CCT: allocated) participants analysed in the group they were allocated?

8\. Are reports of the study free of suggestion of selective outcome reporting?

9\. Were the groups similar at baseline regarding the most important prognostic indicators?

10\. Were co-interventions avoided or similar?

11\. Was the compliance acceptable in all groups?

12\. Was the timing of the outcome assessment similar in all groups?

**^a^** Studies are assessed to originate from the same patient population. Results are reported from the recent (2011) study.

Abbreviations:

NA = Not applicable

COTS = Canadian Orthopaedic Trauma Society

Treatment of middle-third clavicle fractures {#ss8}
--------------------------------------------

Of 6 randomized controlled trials, 3 compared operative treatment to nonoperative treatment ([@CIT0003], [@CIT0010], [@CIT0027]), 2 compared different operative treatments ([@CIT0025], [@CIT0004]), and 1 compared two types of nonoperative treatment ([@CIT0007]). Of 6 controlled clinical trials, 3 compared operative treatment to nonoperative treatment ([@CIT0009], [@CIT0002], [@CIT0011]) and 3 compared operative methods ([@CIT0013], [@CIT0014], [@CIT0021]) ([Table 1](#T1){ref-type="table"}).

*Operative vs. nonoperative treatment.* In a 1-year follow-up of 132 fracture patients comparing plate osteosynthesis to sling, the values in CS were 96 vs. 90 (p \< 0.01) and in DASH score 5 vs. 15 (p \< 0.01). Mean time to radiographic union was 16 weeks after operative treatment and 28 weeks after nonoperative treatment (p = 0.001) ([@CIT0003]).

[@CIT0027] compared elastic stable intramedullary nailing (ESIN) to sling in a 2-year follow-up study of 120 fracture patients. Mean time to union was 12 weeks in the ESIN group and 17 weeks in the sling group (p = 0.01). They found 4% clavicular shortening in the ESIN group and 5% shortening in the sling group. Mean DASH scores were 0.5 and 3 respectively (p = 0.03), and mean Constant scores were 98 and 95 (p = 0.02). Operative treatment secured union better than nonoperative treatment (p = 0.01).

When Hagie pin was compared to a sling, the values in single-assessment numeric evaluation (SANE) were 94 vs. 97 at 1-year follow-up (p \> 0.05) and 96 vs. 98 (p \> 0.05) in L'Insalata. 26/27 fractures in the operative group united and 22/23 fractures in the nonoperative group united (p \> 0.05) ([@CIT0010]).

At 6-month follow-up of 53 fracture patients comparing ESIN to rucksack bandage, mean CS was 98 vs. 90 (p \< 0.001) and mean DASH score was 2 vs. 10 (p \< 0.001). Mean VAS score was 1 vs. 14 (p \< 0.05) ([@CIT0009]).

[@CIT0002] compared rucksack bandage to operative treatment (ESIN or plate) in a controlled clinical study of 120 fracture patients. At 8-month follow-up, mean CS was 97 in the ESIN group, 94 in the plate group, and 90 in the rucksack bandage group (p = 0.01).

[@CIT0011] found a 6-point difference in CS in favor of surgery between patients treated with a sling or plate at 18-month follow-up (p \< 0.0001). At 6-month follow-up, 45/45 fractures in the operative group were united as compared to 20/28 fractures in the nonoperative group (p = 0.002).

*Operative vs. operative treatment.* In a 4-month period, 63/67 fractures stabilized with a 3-dimensionally contoured plate had united compared to 43/66 fractures stabilized with a superior plate (p \< 0.05) ([@CIT0025]).

In patients treated with Rockwood pin (n = 17) or plate (n = 15), mean CS was 92 vs. 88 (p = 0.365) and mean Oxford shoulder score was 45 vs. 45 at the 1-year follow-up. All fractures healed in both treatment groups ([@CIT0004]).

When comparing a locking compression plate (n = 29) with nonlocking plate (n = 35) in elderly patients (60--83 years), union rate was 97% vs. 97%, CS was 92 vs. 89, and VAS was 2.1 vs. 2.2 at 1-year follow-up ([@CIT0021]).

At 1-year follow-up, mean CS was 95 vs. 93 and mean union rate was 100% vs. 97% in patients treated with Knowles pin (n = 56) or plate (n = 32) ([@CIT0014]). In another study comparing Knowles pin (n = 32) and plate (n = 30), mean CS was 85 vs. 84 and union rate was 100% vs. 97% at the 30-month follow-up ([@CIT0013]).

*Nonoperative vs. nonoperative treatment.* At 10-month follow-up comparing mitella (n = 79) to rucksack bandage (n = 78), mean clinical consolidation time was 3.6 vs. 3.8 weeks, and mean VAS was 1.8 vs. 2.6 ([@CIT0007]).

*Complications.*Some authors reported a variety of complications, whereas some reported them very briefly ([Table 4](#T4){ref-type="table"}). Risk to nonunion in patients treated nonoperatively varied from 0% to 29%. Patients treated operatively had notably lower risk to nonunion (0--4%). The operative method (plate, ESIN, Knowles pin, or Hagie pin) had no influence on the nonunion rate. Risk of wound infection was low (0--5%) after operative treatment, except in 2 studies. [@CIT0010] noticed a remarkably high incidence of postoperative infection (in 6/29 patients) after Hagie pin osteosynthesis, and also osteomyelitis in 2 patients. In the study by [@CIT0004], incidence of postoperative infection in the plate group (3/15) was above the average in the literature. The amount of reported complications varied greatly between the studies. For operative treatment the range was 1.5--76% and for nonoperative treatment it was 1.3--93%.

###### 

Reported complications in the studies (n=13) approved to the systematic review of clavicle fractures

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year, country                                              Methods**[^a^](#T4-N1){ref-type="fn"}**   Non-union   Mal-union   Delayed union   Wound infection   Hardwareorbandage irritation   Mechanical failure of osteosynthesis   Protrusion or dislocation of implant   CRPS**[^a^](#T4-N1){ref-type="fn"}**   Brachial plexus symptoms   Other   All complications (%)
  ------------------------------------------------------------------ ----------------------------------------- ----------- ----------- --------------- ----------------- ------------------------------ -------------------------------------- -------------------------------------- -------------------------------------- -------------------------- ------- -----------------------
  [@CIT0007] Netherlands                                             RSB\                                      4/74\                   1/74\                                                                                                                                                                                 0/74\                              5/74 (7)\
                                                                     M                                         0/78                    0/78                                                                                                                                                                                  1/78                               1/78 (1)

  [@CIT0003] Canada                                                  Plate\                                    2/62\       0/62\                       3/62              5/62                           1/62                                                                          0/62\                                  8/62\                      4/62\   23/62 (37)\
                                                                     Sling                                     7/49        9/49                                                                                                                                                       1/49                                   7/49                       7/49    31/49 (63)

  [@CIT0025] China                                                   3DPSP                                                             1/67\                                                                                                                                                                                                                    1/67 (1)\
                                                                                                                                       8/66                                                                                                                                                                                                                     8/66 (12)

  [@CIT0010] United States                                           H pin\                                    1/29\                   1/29            6/29 superf.\     9/29                           1/29                                                                                                                                            2/29\   22/29 (76)\
                                                                     Sling                                     1/28                                    2/29 deep                                                                                                                                                                                        1/28    2/28 (7)

  [@CIT0026], [@CIT0027], Austria **[^b^](#T4-N2){ref-type="fn"}**   ESIN\                                     0/60\       0/60\       2/60\           1/60              5/60                           9/60                                                                                                                 0/60\                      1/60\   18/60 (30)\
                                                                     Sling                                     6/52        2/52        9/52                                                                                                                                                                                  3/52                       0/52    20/52 (39)

  [@CIT0004] UK                                                      RP\                                       0/17\                                   0/17\             1/17\                          1/17\                                                                                                                                           2/17\   4/17 (24)\
                                                                     Plate                                     0/15                                    3/15              0/15                           0/15                                                                                                                                            1/15    4/15 (27)

  [@CIT0009] Germany                                                 ESIN\                                     0/26\                                   0/26\             7/26\                                                                 4/26\                                                                         1/26\                      2/26\   14/26 (54)\
                                                                     RSB                                       2/27                                    0/27              9/27                                                                  0/27                                                                          4/27                       6/27    21/27 (78)

  [@CIT0013] Taiwan                                                  KP\                                       0/32\                                   0/32\             4/32\                          0/32\                                                                                                                                                   4/32 (13)\
                                                                     Plate                                     1/30                                    1/30              12/30                          2/30                                                                                                                                                    16/30 (53)

  [@CIT0014] Taiwan                                                  KP\                                       0/56\                                   0/56\             4/56\                          0/56\                                                                                                                                                   4/56 (7)\
                                                                     Plate                                     1/32                                    1/32              12/32                          1/32                                                                                                                                                    15/32 (47)

  [@CIT0021] Taiwan                                                  LCP\                                      1/29\                                   0/29\             11/29\                         0/29\                                                                                                                                                   12/29 (41)\
                                                                     NLP                                       1/35                                    1/35              14/35                          4/35                                                                                                                                                    20/35 (57)

  [@CIT0008] Taiwan                                                  HP\                                       0/35\                                                                                    9/35\                                  0/35\                                                                                                            9/35 (26)\
                                                                     TB                                        0/30                                                                                     0/30                                   5/30                                                                                                             5/30 (12)

  [@CIT0002] Germany                                                 RSB\                                      1/47\       1/47\       1/47\           \                                                0/47\                                                                                                                0/47\                      4/47\   7/47 (15)\
                                                                     Plate\                                    0/53\       0/53\       0/53\           2/53\                                            4/53\                                                                                                                0/53\                      1/53\   7/53 (13)\
                                                                     ESIN                                      0/20        0/20        0/20            0/20                                             1/20                                                                                                                 1/20                       1/20    3/20 (15)

  [@CIT0011], India                                                  Plate\                                    0/45\       2/45\       2/45\                             4/45                           2/45                                                                                                                                            2/45\   12/45 (27)\
                                                                     Sling                                     8/28        10/28       0/28                                                                                                                                                                                                             8/28    26/28 (93)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**^a^** Abbreviations:

CRPS= Complex regional pain syndrome

RSB=Rucksack bandage

M = Mitella

COTS = Canadian Orthopaedic Trauma Society

3DP = Three-dimensional plate

SP = Superior plate

H pin = Hagie pin

ESIN = Elastic stable intramedullary nail

RP = Rockwood pin

KP = Knowles pin

LCP = Locking compression plate

NLP = Non-locking plate

HP = Hook plate

TB = Tension band

**^b^** Studies are assessed to originate from the same patient population. Results are reported from the recent (2011) study.

Synthesis of evidence {#ss9}
---------------------

We classified pain, function, and disability as having critical clinical relevance. Delayed union, nonunion, and complications were classified as being important in clinical relevance. No publication bias appeared in the studies included.

*Operative vs. nonoperative treatment.* Data were extracted from 3 randomized controlled trials ([@CIT0003], [@CIT0010], [@CIT0027]) and 3 controlled clinical trials ([@CIT0009], [@CIT0002], [@CIT0011]). In favor of surgery, there was very limited evidence (level D) of considerable effectiveness of pain relief at 1--5 months and of low effectiveness (level D) at 6--7 months. Using function (Constant score), moderate-quality evidence (level B) of considerable effectiveness at 6 weeks and of low effectiveness (level B) after the 6-month follow-up was found in favor of surgery. Moderate-quality evidence (level B) of considerable effectiveness in favor of surgery using disability (DASH, L'Insalata) was found at 6 weeks and of low effectiveness (level B) after the 6-month follow-up. Moderate-quality evidence (level B) of similar risk of relatively mild complications was found in patients treated operatively or nonoperatively. There was moderate-quality evidence (level B) of delayed union and nonunion being more common in patients treated nonoperatively than operatively.

*Operative vs. operative treatment.* Evidence was extracted from 2 randomized controlled trials ([@CIT0025], [@CIT0004]) and 3 controlled clinical trials ([@CIT0013], [@CIT0014], [@CIT0021]). There was very limited evidence (level D) of no difference in postoperative pain at 3 days between locking plate and nonlocking plate in elderly patients. Limited evidence (level C) was found of no difference in function (Constant score) at 1 year and later between pin and plate, or locking plate and nonlocking plate, in elderly patients. There was very limited evidence (level D) of smaller need for reoperations in elderly patients initially treated with locking plate than among those treated with nonlocking plate. Limited evidence (level C) of no difference in complications was found in treatment with pin or plate osteosynthesis. There was moderate evidence (level B) that osteosynthesis method has no effect on incidence of delayed union or nonunion.

*Nonoperative vs. nonoperative treatment.* Evidence was extracted from 1 randomized controlled trial ([@CIT0007]). There was limited evidence (level C) of no difference in pain between rucksack bandage and mitella at 2 weeks and 6 months.

Treatment of lateral and medial clavicle fractures {#ss10}
--------------------------------------------------

No controlled trials were found on medial clavicle fractures. We found 1 controlled clinical trial on lateral clavicle fractures, comparing hook plate to tension band wire ([@CIT0008]). In this study, average time for union was similar between the groups. When comparing range of movement and function between the hook plate group and the tension band group, elevation was 160° vs. 165°, abduction was 165° vs. 168°, and Oxford shoulder score 18 vs. 21.

No major complications appeared in this study. Complications consisted of implant-related subacromial erosion in the hook plate group and K-wire migration in the tension band group.

According to this single study, there was very limited evidence (level D) of no difference in function (ROM, Oxford shoulder score) between hook plate and tension band wire at the 6-month follow-up. There was also very limited evidence (level D) that the osteosynthesis method (hook plate or tension band wire) has no effect on incidence of delayed union or nonunion, and very limited evidence (level D) of no difference in complications between patients treated with hook plate or tension band wire.

Discussion {#ss11}
==========

We found 6 randomized controlled trials and 7 controlled clinical trials on clavicle fractures published between 1966 until the end of March, 2011. Considering the relevance of the topic, surprisingly few trials have been published, especially on medial and lateral fractures. None of the studies analyzed the correlation between union or nonunion and functional results. Overall, the evidence was mainly graded as limited (level C) or very limited (level D). The moderate-quality evidence (level B) can be summarized as follows: (1) The operative treatment of middle-third clavicle fractures has considerable effectiveness on better function, particularly after short-term follow-up; (2) The operative treatment of middle-third clavicle fractures has considerable effectiveness on less disability, particularly after short-term follow-up; (3) There was similar risk of relatively mild complications after nonoperative or operative treatment of middle-third clavicle fractures; (4) Delayed union and nonunion were more common in patients treated nonoperatively than in those treated operatively; (5) Osteosynthesis method had no effect on the incidence of delayed union or nonunion.

There was only 1 study on lateral clavicle fractures, and it was graded as having very limited (level D) evidence. No studies were found on medial clavicle fractures. There were no major or perilous complications, and evidently some complications were related to a particular treatment option. No clear conclusion can be drawn from the incidence of complications due to the highly heterogeneous reporting.

Some systematic reviews of clavicle fractures have been published earlier. In a review of 2,144 midshaft clavicle fractures, [@CIT0029] reported a 4% nonunion rate in total. With nonoperative treatment, the nonunion rate was 6% for all fractures and 15% for displaced fractures. When treated nonoperatively, fracture displacement, fracture comminution, female gender, and ageing were associated with nonunion. That particular review found plating to be more successful in fracture consolidation than nonoperative treatment, while the results were contradictory when comparing intramedullary fixation and nonoperative treatment. The review included 3 randomized controlled trials with methodological limitations, and also retrospective cohort studies and case series. There was only 1 study comparing different operative methods. Zlowodzki et al. reported only nonunion, infection, and fixation failures while functional outcome measures were not analyzed.

Two Cochrane reviews on clavicle fractures have been published. [@CIT0015] analyzed 3 studies comparing nonoperative treatments for middle-third clavicle fractures, but they were not able to evaluate the effectiveness of different treatment options. [@CIT0016] also analyzed studies comparing different operative methods of acute middle-third fractures or nonunion. The review included 3 studies and concluded that there is limited evidence regarding the effectiveness of different operative methods.

*Limitations.* The present work has some limitations. Despite the extensive study search, it is possible that we did not find all the eligible trials. We excluded 3 studies because of a foreign language, and thus may have been missed some information. The quality of the studies varied. There were 2 studies with high risk of bias. Major shortcomings were included, such as improper method of randomization and concealment of allocation, analysis not based on the intention-to-treat principle, and especially unsystematic and insufficient reporting of studies. Due to the clinical heterogeneity (patients, interventions, outcome measures, morphology, and displacement of fractures) we could not perform a meta-analysis. In addition, we were unable to calculate the number--needed-to-treat figures for the trials included, as there were no data for assessment of the minimal clinically important differences or patient-acceptable symptom states ([@CIT0012]).

*Implications for practice.* There is moderate-quality evidence that operative treatment of middle-third clavicle fractures leads to slightly better functional results than nonoperative treatment, particularly after short-term follow-up. Also, fracture union was better achieved with surgery. After 6 months, the benefits of operative treatment were very small, as most of the patients also recovered with nonoperative treatment. The studies provide evidence that nonoperative treatment of middle-third clavicle fractures usually leads to adequate functional results, pain relief, and union rates. Operative treatment should be considered to achieve the union for active patients who need to recover to the previous level of activity in the shortest possible time.

*Implications for research.* High-quality, randomized controlled trials comparing plate osteosynthesis, intramedullary nailing, and nonoperative treatment are needed. In particular, randomized controlled trials of lateral and medial clavicle fractures are required. For the moment, is impossible to draw any conclusions regarding treatment of these fractures. More data are required to assess the effectiveness of locking plates and pre-contoured plates in middle and lateral clavicle fractures. Future studies should also assess the impact of fracture union or nonunion on functional outcomes and determine whether to treat operatively only those patients with symptomatic nonunion.
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